Optometrists in Winnsboro, LA Accepting Medicare
3 Optometrists found. Showing 1 - 3
 W E Marionneaux Jr Od Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6609 Main St, Winnsboro, LA 71295 Phone: 318-435-5145 Fax: 318-435-9476 |
 Dr. Albert Charles Burns Jr., O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3360 Front St, Winnsboro, LA 71295 Phone: 318-435-9139 |
Mr. Willard E Marionneaux Jr., OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6609 Main Street, Winnsboro, LA 71295 Phone: 318-435-5145 Fax: 318-435-9476 |
News Archive
New genome-based, personalized cancer test from iKaryos Diagnostics
iKaryos Diagnostics, a provider of molecular cancer testing, announced today the availability of a genome-based, personalized cancer test which uses single nucleotide polymorphism (SNP) arrays to digitally assess the DNA of cancer cells.
World's largest research initiative to mutate all mouse genes
The world's largest research initiative to mutate all mouse genes is now able to reach the summit because the ambitious EUCOMMTOOLS project started on October 1, 2010. This project is being coordinated by Helmholtz Zentrum München and will finalize the groundwork for the analysis of all mouse gene functions. The findings will contribute to a better understanding of the pathogenesis of widespread diseases such as Alzheimer's, depression, diabetes, chronic lung diseases or cancer.
Pan-COVID-19 vaccine protects mice against SARS-CoV-2 variants
Researchers in the United States have identified short peptide sequences in the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that are immunogenic in a mouse model and may provide protection against viral variants.
Is niclosamide a potential SARS-CoV-2 antiviral inhibitor?
Niclosamide is an antihelminthic drug, historically used to treat tapeworm infestations, though has been investigated and repurposed for use against SARS-CoV-2. In a new study recently uploaded to the preprint server bioRxiv* by Garrett et al. (July 12, 2021), the drug demonstrates the ability to reorganize the lipid profile of SARS-CoV-2 infected Vero E6 cells, thereby limiting virus replication.
› Verified 3 days ago
Physical Therapists
Occupational Therapists
Speech-Language Pathologists
Optometrists
Chiropractors